110 related articles for article (PubMed ID: 8041257)
1. Preparation of intramolecularly cross-linked hemoglobins.
Walder RY; Andracki ME; Walder JA
Methods Enzymol; 1994; 231():274-80. PubMed ID: 8041257
[No Abstract] [Full Text] [Related]
2. Molecular dynamics of a hemoglobin crosslinking reaction.
Pavlik PA; Boyd MK; Olsen KW
Biopolymers; 1996 Oct; 39(4):615-8. PubMed ID: 8837523
[No Abstract] [Full Text] [Related]
3. Thermal stabilities of hemoglobins crosslinked with different length reagents.
Huang H; Olsen KW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):719-24. PubMed ID: 7994393
[TBL] [Abstract][Full Text] [Related]
4. Molecular weight determinations of o-raffinose-polymerized human hemoglobin.
Moore GL; Fishman RM; Ledford ME; Zegna A; Hsia JC; Song DL; Wong LT; Er SS
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):293-6. PubMed ID: 1391445
[No Abstract] [Full Text] [Related]
5. Derivatives of hemoglobin prepared by reaction with aryl or alkyl isothiocyanates.
Currell DL
Methods Enzymol; 1994; 231():281-7. PubMed ID: 8041258
[No Abstract] [Full Text] [Related]
6. Conformational and functional characteristics of bovine hemoglobin.
Fronticelli C; Bucci E
Methods Enzymol; 1994; 231():150-63. PubMed ID: 8041248
[No Abstract] [Full Text] [Related]
7. Diaspirin crosslinked hemoglobin (DCLHb) polymerization.
Hai TT; Nelson D; Pereira D; Srnak A
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):923-31. PubMed ID: 7994419
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic protection from autoxidation for crosslinked hemoglobins.
Yang T; Olsen KW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies.
Nelson D; Azari M; Brown R; Burhop K; Bush S; Catarello J; Chuang H; Downing C; Estep T; Loewen A
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):423-7. PubMed ID: 1391458
[TBL] [Abstract][Full Text] [Related]
10. Is it necessary to improve the intravascular retention of hemoglobin solutions?
Greenburg AG; Peskin GW; Hoyt DB; Moores WY
Crit Care Med; 1982 Apr; 10(4):266-9. PubMed ID: 7067476
[No Abstract] [Full Text] [Related]
11. Pilot-scale preparation of hemoglobin solutions.
Winslow RM; Chapman KW
Methods Enzymol; 1994; 231():3-16. PubMed ID: 8041260
[No Abstract] [Full Text] [Related]
12. Polymerization of modified diaspirin cross-linked hemoglobin (DCLHb) with 1,6-bismaleimic-hexane.
Qi D; Wang P; Chen C; Guo S; Wang X
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1069-74. PubMed ID: 26838092
[TBL] [Abstract][Full Text] [Related]
13. Large scale preparation of functional human placental hemoglobin for use in blood substitutes.
Fasan G; Vigneron C; Dellacherie E; Grandgeorge M
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):489-91. PubMed ID: 1391468
[No Abstract] [Full Text] [Related]
14. Mechanism for the increase in solubility of deoxyhemoglobin S due to cross-linking the beta chains between lysine-82 beta 1 and lysine-82 beta 2.
Chatterjee R; Walder RY; Arnone A; Walder JA
Biochemistry; 1982 Nov; 21(23):5901-9. PubMed ID: 6817783
[No Abstract] [Full Text] [Related]
15. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
[TBL] [Abstract][Full Text] [Related]
16. Bis(pyridoxal) polyphosphates as specific intramolecular cross-linking agents for hemoglobin.
Benesch RE
Methods Enzymol; 1994; 231():267-74. PubMed ID: 8041256
[No Abstract] [Full Text] [Related]
17. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
[TBL] [Abstract][Full Text] [Related]
18. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.
Chatterjee R; Iwai Y; Walder RY; Walder JA
J Biol Chem; 1984 Dec; 259(23):14863-73. PubMed ID: 6501320
[TBL] [Abstract][Full Text] [Related]
19. Molecular engineering of proteins with predefined function. Part I: Design of a hemoglobin-based oxygen carrier.
Sivan S; Lotan N
Biomol Eng; 2003 Mar; 20(3):83-90. PubMed ID: 12684069
[TBL] [Abstract][Full Text] [Related]
20. Disuccinimidyl suberate cross-linked hemoglobin as a novel red blood cell substitute.
Lu X; Zheng C; Xu Y; Su Z
Sci China C Life Sci; 2005 Feb; 48(1):49-60. PubMed ID: 15844357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
